Paper41592151
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.
Liu N and 14 others. Sci Signal, 2026. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer. Papers, record 41592151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41592151
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ErbB Receptors | Major topic |
| Receptors, N-Methyl-D-Aspartate | Major topic |
| Morphine | Major topic |
| Cancer Pain | Major topic |
| Mouth Neoplasms | Major topic |
| Trigeminal Ganglion | Major topic |
| Drug Tolerance | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Cell Line, Tumor | |
| Carcinoma, Squamous Cell | |
| Analgesics, Opioid | |
| Male | |
| Signal Transduction |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DE032501 | NIDCR NIH HHS | United States | R01DE032501 | PubMed | NIH RePORTER |
| R01 NS102722 | NINDS NIH HHS | United States | R01NS102722 | PubMed | NIH RePORTER |
| RM1 DE033491 | NIDCR NIH HHS | United States | RM1DE033491 | PubMed | NIH RePORTER |
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28,923,838 | Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT. | Mol Cancer Res | 2017 | https://conductscience.org/library/papers/28923838 | PubMed |
| 2 | 36,172,037 | The impact of tumor immunogenicity on cancer pain phenotype using syngeneic oral cancer mouse models. | Front Pain Res (Lausanne) | 2022 | https://conductscience.org/library/papers/36172037 | PubMed |
| 3 | 34,520,454 | Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway. | PLoS One | 2021 | https://conductscience.org/library/papers/34520454 | PubMed |
| 4 | 30,788,514 | Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain. | Cell Mol Life Sci | 2019 | https://conductscience.org/library/papers/30788514 | PubMed |
| 5 | 24,384,067 | Validation and implementation of a novel high-throughput behavioral phenotyping instrument for mice. | J Neurosci Methods | 2014 | https://conductscience.org/library/papers/24384067 | PubMed |
| 6 | 7,908,958 | Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. | J Neurosci | 1994 | https://conductscience.org/library/papers/7908958 | PubMed |
| 7 | 11,359,139 | A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis. | Laryngoscope | 2001 | https://conductscience.org/library/papers/11359139 | PubMed |
| 8 | 35,416,080 | Advances in Head and Neck Cancer Pain. | J Dent Res | 2022 | https://conductscience.org/library/papers/35416080 | PubMed |
| 9 | 31,215,332 | The upregulation of EGFR in the dorsal root ganglion contributes to chronic compression of dorsal root ganglions-induced neuropathic pain in rats. | Mol Pain | 2019 | https://conductscience.org/library/papers/31215332 | PubMed |
| 10 | 26,204,818 | EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. | Neuroscience | 2015 | https://conductscience.org/library/papers/26204818 | PubMed |
| 11 | 31,917,773 | The dichotomous role of epiregulin in pain. | Pain | 2020 | https://conductscience.org/library/papers/31917773 | PubMed |
| 12 | 34,096,178 | Addressing opioid tolerance and opioid-induced hypersensitivity: Recent developments and future therapeutic strategies. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/34096178 | PubMed |
| 13 | 28,866,730 | EGFR-targeted therapies in the post-genomic era. | Cancer Metastasis Rev | 2017 | https://conductscience.org/library/papers/28866730 | PubMed |
| 14 | 29,913,887 | Epithelial growth factor receptor (EGFR)-inhibition for relief of neuropathic pain-A case series. | Scand J Pain | 2013 | https://conductscience.org/library/papers/29913887 | PubMed |
| 15 | 30,578,671 | μ-Opioid receptors in primary sensory neurons are essential for opioid analgesic effect on acute and inflammatory pain and opioid-induced hyperalgesia. | J Physiol | 2019 | https://conductscience.org/library/papers/30578671 | PubMed |
| 16 | 34,252,035 | Protein Kinase C-Mediated Phosphorylation and α2δ-1 Interdependently Regulate NMDA Receptor Trafficking and Activity. | J Neurosci | 2021 | https://conductscience.org/library/papers/34252035 | PubMed |
| 17 | 16,722,544 | The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications. | Radiat Oncol | 2006 | https://conductscience.org/library/papers/16722544 | PubMed |
| 18 | 22,209,887 | Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma. | Oncol Rep | 2012 | https://conductscience.org/library/papers/22209887 | PubMed |
| 19 | 34,206,026 | EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34206026 | PubMed |
| 20 | 31,106,835 | Relief of Neuropathic Pain Through Epidermal Growth Factor Receptor Inhibition: A Randomized Proof-of-Concept Trial. | Pain Med | 2019 | https://conductscience.org/library/papers/31106835 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,183,213 | Epidermal growth factor receptor signaling modulates postoperative pain and inflammatory responses. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183213 | PubMed |
| 42,169,107 | The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42169107 | PubMed |
| 41,964,002 | Sex influences on tumor innervation. | Biol Sex Differ | 2026 | https://conductscience.org/library/papers/41964002 | PubMed |
| 41,928,905 | Peripheral Nerve-Cancer Interactions in the Tumor Microenvironment: A Three-Dimensional Framework Integrating Mechanisms, Modulators, and Therapeutic Strategies. | Research (Wash D C) | 2026 | https://conductscience.org/library/papers/41928905 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41592151
GET https://conductscience.org/api/papers/v1/41592151/references?page=2